RT Journal Article
SR Electronic
T1 New insights in Ulcerative Colitis Associated Gut Microbiota in South American Population: <em>Akkermansia</em> and <em>Collinsella</em>, two distinctive genera found in Argentine subjects
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.29.20164764
DO 10.1101/2020.07.29.20164764
A1 Ayelén, Rosso
A1 Pablo, Aguilera
A1 Sofía, Quesada
A1 Jimena, Cerezo
A1 Renata, Spiazzi
A1 Carolina, Conlon
A1 Claudia, Milano
A1 Iraola, Gregorio
A1 Federico, Coluccio Leskow
A1 Alberto, Penas-Steinhardt
A1 Belforte Fiorella, S.
YR 2020
UL http://medrxiv.org/content/early/2020/08/03/2020.07.29.20164764.1.abstract
AB Background Globally, ulcerative colitis (UC) is the most common form of intestinal inflammation, which is believed to be the result of a deregulated immune system response to commensal microbiota in a genetically susceptible host. Multicellular organisms rely heavily on their commensal symbiotic microbiota, whose composition is closely related to intrinsic local characteristics and regulated or modified by environmental factors. In the present study we aim to describe the unknown gut microbiota of patients with UC in comparison with healthy individuals in order to find novel biomarkers for UC in our region.Methods We evaluated 46 individuals, 26 healthy non-UC controls and 20 UC patients, from the metropolitan area of Buenos Aires (BA), Argentina. Clinical features, biochemical tests and anthropometric measurements were determined. Fecal samples were collected and DNA was extracted for microbiota analysis. The hypervariable regions V3-V4 of the bacterial 16SR gene were sequenced using a MiSeq platform and sequences were analyzed using the QIIME2 environment. In addition, we looked for differential functional pathways using PICRUSt and compared the performance of three machine learning models to discriminate the studied individuals, using taxa and functional annotations.Results All UC patients were under clinical treatment with 70% of individuals in remission. We found no significant differences in gut microbiota richness or evenness between UC patients and non-UC controls (alpha diversity). Remarcably, microbial compositional structure within groups (beta diversity) showed differences: At the phylum level, Verrucomicrobia was overrepresented in controls while Actinobacteria was distinctive of UC patients; At the genus level Bacteroides and Akkermancia were significantly more abundant among controls while Eubacterium and Collinsella in UC patients. In addition, our results showed that carbohydrates metabolism was preponderant in UC patients, not observing a distinctive biochemical pathway for the healthy non-UC controls. Finally, in order to define a robust classifying method in our population, we evaluated the capability of three machine learning models to classify individuals. Our results reinforced the idea of functional compensation in microbiome communities, as models that used KEGG orthologs annotations had better capabilities than taxonomy to distinguish UC patients.Conclusions Our study provides new knowledge on the differences and similarities of the gut microbiota of UC patients as compared to non-UC controls of our population. This allows not only the association of local changes in gut microbial diversity with the pathology process, but also the future development of personalized nutritional and pharmacological therapies through the use of omic strategies describing the metagenomic profiles of the Argentine population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the Department of Basic Sciences of the National University of Lujan (UNLu), Florencio Fiorini Foundation, Barcelo Foundation, Argentine Society of Gastroenterology and the National Agency for Science and Technology (PICT2017-2406).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study received approval by the Ethics Committees of Hospital Espanol of BA (for non-UC control population) and Hospital Nacional Prof. Alejandro Posadas (for UC patients), according to local regulations and Helsinki declaration. Written informed consent was obtained from all study participants. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData accessionRaw sequences of 16S rRNA gene reported in this article were deposited in NCBI Short Read Archive (SRA) and are accessible under the accession number PRJNA646271.